These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
294 related items for PubMed ID: 15717029
21. Multiple sclerosis: hyperintense lesions in the brain on nonenhanced T1-weighted MR images evidenced as areas of T1 shortening. Janardhan V, Suri S, Bakshi R. Radiology; 2007 Sep; 244(3):823-31. PubMed ID: 17690319 [Abstract] [Full Text] [Related]
22. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force. Miller DH, Albert PS, Barkhof F, Francis G, Frank JA, Hodgkinson S, Lublin FD, Paty DW, Reingold SC, Simon J. Ann Neurol; 1996 Jan; 39(1):6-16. PubMed ID: 8572668 [Abstract] [Full Text] [Related]
25. An abnormal periventricular magnetization transfer ratio gradient occurs early in multiple sclerosis. Brown JW, Pardini M, Brownlee WJ, Fernando K, Samson RS, Prados Carrasco F, Ourselin S, Gandini Wheeler-Kingshott CA, Miller DH, Chard DT. Brain; 2017 Feb; 140(2):387-398. PubMed ID: 28043954 [Abstract] [Full Text] [Related]
28. Magnetic resonance studies of abnormalities in the normal appearing white matter and grey matter in multiple sclerosis. Miller DH, Thompson AJ, Filippi M. J Neurol; 2003 Dec; 250(12):1407-19. PubMed ID: 14673572 [Abstract] [Full Text] [Related]
29. Impact of disease-modifying therapies on brain and spinal cord atrophy in multiple sclerosis. Rudick RA. J Neuroimaging; 2004 Jul; 14(3 Suppl):54S-64S. PubMed ID: 15228760 [Abstract] [Full Text] [Related]
31. MR in the diagnosis and monitoring of multiple sclerosis: an overview. Rovira A, León A. Eur J Radiol; 2008 Sep; 67(3):409-14. PubMed ID: 18434066 [Abstract] [Full Text] [Related]
32. Axonal pathology in multiple sclerosis: relationship to neurologic disability. Trapp BD, Ransohoff R, Rudick R. Curr Opin Neurol; 1999 Jun; 12(3):295-302. PubMed ID: 10499174 [Abstract] [Full Text] [Related]
34. Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study. Simone IL, Tortorella C, Federico F, Liguori M, Lucivero V, Giannini P, Carrara D, Bellacosa A, Livrea P. J Neurol Sci; 2001 Jan 01; 182(2):143-50. PubMed ID: 11137520 [Abstract] [Full Text] [Related]
35. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Miller DH, Barkhof F, Frank JA, Parker GJ, Thompson AJ. Brain; 2002 Aug 01; 125(Pt 8):1676-95. PubMed ID: 12135961 [Abstract] [Full Text] [Related]
36. New treatment measurements for treatment effects on relapses and progression. Tintoré M, Sastre-Garriga J. J Neurol Sci; 2008 Nov 15; 274(1-2):80-3. PubMed ID: 18822433 [Abstract] [Full Text] [Related]
37. Magnetic resonance techniques to quantify tissue damage, tissue repair, and functional cortical reorganization in multiple sclerosis. Filippi M, Agosta F. Prog Brain Res; 2009 Nov 15; 175():465-82. PubMed ID: 19660674 [Abstract] [Full Text] [Related]
38. Measures of brain and spinal cord atrophy in multiple sclerosis. Losseff NA, Miller DH. J Neurol Neurosurg Psychiatry; 1998 May 15; 64 Suppl 1():S102-5. PubMed ID: 9647295 [Abstract] [Full Text] [Related]
39. Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Truyen L, van Waesberghe JH, van Walderveen MA, van Oosten BW, Polman CH, Hommes OR, Adèr HJ, Barkhof F. Neurology; 1996 Dec 15; 47(6):1469-76. PubMed ID: 8960729 [Abstract] [Full Text] [Related]
40. [Magnetic resonance imaging in multiple sclerosis]. Tourbah A, Berry I. Pathol Biol (Paris); 2000 Mar 15; 48(2):151-61. PubMed ID: 10815291 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]